1. Sjaarda RN, Thompson JT. Ryan SJ, Wilkinson CP, editors. Macular hole. Retina. 2006. Vol. 3, Surgical retina:4th ed. Philadelphia: Elsevier;2527–2542.
2. Smiddy WE, Feuer W, Cordahi G. Internal limiting membrane peeling in macular hole surgery. Ophthalmology. 2001. 108:1471–1476.
3. Freeman WR, Azen SP, Kim JW, et al. The Vitrectomy for Treatment of Macular Hole Study Group. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes: results of a multicentered randomized clinical trial. Arch Ophthalmol. 1997. 115:11–21.
4. Mester V, Kuhn F. Internal limiting membrane removal in the management of full-thickness macular holes. Am J Ophthalmol. 2000. 129:769–777.
5. Smiddy WE, Pimentel S, Williams GA. Macular hole surgery without using adjunctive additives. Ophthalmic Surg Lasers. 1997. 28:713–717.
6. Kasuga Y, Arai J, Akimoto M, Yoshimura N. Optical coherence tomograghy to confirm early closure of macular holes. Am J Ophthalmol. 2000. 130:675–676.
7. Brooks HL Jr. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology. 2000. 107:1939–1948.
8. Lai MM, Williams GA. Anatomical and visual outcomes of idiopathic macular hole surgery with internal limiting membrane removal using low-concentration indocyanine green. Retina. 2007. 27:477–482.
9. Banker AS, Freeman WR, Azen SP, Lai MY. A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes: Vitrectomy for Macular Hole Study Group. Arch Ophthalmol. 1999. 117:1499–1502.
10. Cheng L, Azen SP, El-Bradey MH, et al. Effects of preoperative and postoperative epiretinal membranes on macular hole closure and visual restoration. Ophthalmology. 2002. 109:1514–1520.
11. Ullrich S, Haritoglou C, Gass C, et al. Macular hole size as a prognostic factor in macular hole surgery. Br J Ophthalmol. 2002. 86:390–393.
12. Haritoglou C, Neubauer AS, Reiniger IW, et al. Long-term functional outcome of macular hole surgery correlated to optical coherence tomography measurements. Clin Experiment Ophthalmol. 2007. 35:208–213.
13. Uemoto R, Yamamoto S, Aoki T, et al. Macular configuration determined by optical coherence tomography after idiopathic macular hole surgery with or without internal limiting membrane peeling. Br J Ophthalmol. 2002. 86:1240–1242.
14. Villate N, Lee JE, Venkatraman A, Smiddy WE. Photoreceptor layer features in eyes with closed macular holes: optical coherence tomography findings and correlation with visual outcomes. Am J Ophthalmol. 2005. 139:280–289.
15. Kang SW, Ahn K, Ham DI. Types of macular hole closure and their clinical implications. Br J Ophthalmol. 2003. 87:1015–1019.
16. Guyer DR, Green WR, de Bustros S, Fine SL. Histopathologic features of idiopathic macular holes and cysts. Ophthalmology. 1990. 97:1045–1051.
17. Funata M, Wendel RT, de la Cruz Z, Green WR. Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina. 1992. 12:289–298.
18. Frangieh GT, Green WR, Engel HM. A histopathologic study of macular cysts and holes. Retina. 1981. 1:311–336.
19. Srinivasan VJ, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006. 113:2054.e1–2054.e14.
20. Hangai M, Ojima Y, Gotoh N, et al. Three-dimensional imaging of macular holes with high-speed optical coherence tomography. Ophthalmology. 2007. 114:763–773.
21. Sjaarda RN, Frank DA, Glaser BM, et al. Resolution of an absolute scotoma and improvement of relative scotomata after successful macular hole surgery. Am J Ophthalmol. 1993. 116:129–139.
22. Lee JE, Lee SU, Jea SY, et al. Reorganization of photoreceptor layer on optical coherence tomography concurrent with visual improvement after macular hole surgery. Korean J Ophthalmol. 2008. 22:137–142.
23. Kusuhara S, Teraoka Escano MF, Fujii S, et al. Prediction of postoperative visual outcome based on hole configuration by optical coherence tomography in eyes with idiopathic macular holes. Am J Ophthalmol. 2004. 138:709–716.
24. Smiddy WE, Glaser BM, Thompson JT, et al. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes: preliminary anatomic results of a multicenter prospective randomized study. Retina. 1993. 13:296–301.
25. Paques M, Chastang C, Mathis A, et al. Platelets in Macular Hole Surgery Group. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Ophthalmology. 1999. 106:932–938.
26. Kim SS, Smiddy WE, Feuer WJ, Shi W. Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery. Retina. 2008. 28:1408–1415.